Request for Prototype: MCDC2009: Development of Naloxone Multi-10 mg Dose Use Vial

Funding Agency:
Medical CBRN Defense Consortium

On May 27, 2020, the MCDC Consortium Management Firm released Request for Prototype Proposal MCDC-RPP-20-09 on the Members Only portion of the MCDC Website. This solicitation has been put forth by Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND). This solicitation is for the Treatment Objective area and contains one Sub-Objective area:

 

Treatment (TRE-20-09) – Development of Naloxone Multi-10 mg Dose Use Vial

 

Enhanced White Paper Due Date: 26 June 2020 at 12:00 PM NOON ET

 

Agency Website

Eligibility Requirements

Only those members of the MCDC who have executed the MCDC Member Agreement (CMA) and are deemed to be “Members in Good Standing” prior to the due date for Enhanced Whitepapers will be eligible to have their submissions evaluated. An Offeror that submits an Enhanced Whitepaper prior to executing the CMA or is not a “Member in Good Standing” does so solely at its own risk and neither the CMF nor the Government has any responsibility for costs associated with such a submission.

Funding Type

Grant

Eligibility

Faculty

Category

Engineering and Physical Sciences
Medical
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

June 26, 2020